Evidence map›Paper›PMID 32312770›Full record

ArticleAnnals of the rheumatic diseases2020

Blood-based test for diagnosis and functional subtyping of familial Mediterranean fever.

Hanne Van Gorp, Linyan Huang, Pedro Saavedra, Marnik Vuylsteke, Tomoko Asaoka, Giusi Prencipe, Antonella Insalaco, Benson Ogunjimi, Jerold Jeyaratnam, Ilaria Cataldo and 13 more

2 registry-linked trialsOpen access · hybridAbstract readEvaluation Study
In one paragraph

Article in Annals of the rheumatic diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05447351 unknown statusnot on this mapstarted 2023, after this paper: background citation

Effects of Personalized Dietary and Lifestyle Treatments on the Reduction of Cardiovascular and Metabolic Risk in Overweight and Obese Patients

Typeobservational_patient_registrySponsorUniversity of BariRan2023 to 2025Enrolled200ConditionsOverweight and Obesity, Cardiovascular Diseases, Metabolic Syndrome, Non-Alcoholic Fatty Liver Disease
NCT07035704 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

De-Risking Metabolic, Environmental and Behavioral Determinants of Obesity in Children, Adolescents and Young Adults

TypeinterventionalSponsorpiero portincasaRan2025 to 2027Enrolled200ConditionsOverweight (BMI &gt, 25)ArmsMeD enriched with mushrooms, MeD enriched the Lebanese herbal mixture Za'atar, MeD Diet + semaglutinine or compatible treatment+ Za'atar or Mushroom (to be defined)
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 7 institutions in 4 countries.

Hanne Van GorpVIB Center for Inflammation Research, Zwijnaarde, Belgium.
Linyan HuangVIB Center for Inflammation Research, Zwijnaarde, Belgium.
Pedro SaavedraVIB Center for Inflammation Research, Zwijnaarde, Belgium.ORCID 0000-0002-7659-4533
Marnik VuylstekeGNOMIXX, Statistics for Genomics, Melle, Belgium.
Tomoko AsaokaVIB Center for Inflammation Research, Zwijnaarde, Belgium.
Giusi PrencipeRheumatology Unit, Bambino Gesù Children's Hospital, Rome, Italy.
Antonella InsalacoRheumatology Unit, Bambino Gesù Children's Hospital, Rome, Italy.
Benson OgunjimiDepartment of Paediatrics, Antwerp University Hospital, Edegem, Belgium.
Jerold JeyaratnamDepartment of Pediatric Rheumatology, University Medical Center Utrecht, Utrecht, Netherlands.
Ilaria CataldoDepartment of Biosciences, Biotechnologies and Biopharmaceutics, Università degli Studi di Bari "Aldo Moro", Bari, Italy.
Peggy JacquesVIB Center for Inflammation Research, Zwijnaarde, Belgium.ORCID 0000-0001-9227-257X
Karim VermaelenDepartment of Internal Medicine and Paediatrics, Ghent University, Gent, Belgium.
Melissa DullaersVIB Center for Inflammation Research, Zwijnaarde, Belgium.
Rik JoosAntwerp centre for paediatric rheumatology and auto-inflammatory diseases, Antwerp Hospital Network and Antwerp University Hospital, Antwerp, Belgium.
Vito SabatoAntwerp centre for paediatric rheumatology and auto-inflammatory diseases, Antwerp Hospital Network and Antwerp University Hospital, Antwerp, Belgium.
Alessandro StellaDivision of Medical Genetics, Department of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", Bari, Italy.
Joost FrenkelDepartment of Pediatric Rheumatology, University Medical Center Utrecht, Utrecht, Netherlands.
Fabrizio De BenedettiRheumatology Unit, Bambino Gesù Children's Hospital, Rome, Italy.
Joke DehoorneVIB Center for Inflammation Research, Zwijnaarde, Belgium.
Filomeen HaerynckClinical Immunology Research Lab, Centre for Primary Immunodeficiency Ghent, Ghent University Hospital, Gent, Belgium.
Giuseppe CalamitaDepartment of Biosciences, Biotechnologies and Biopharmaceutics, Università degli Studi di Bari "Aldo Moro", Bari, Italy.
Piero PortincasaDivision of Internal Medicine, Department of Biomedical Sciences and Human Oncology, Clinica Medica "A Murri", University of Bari "Aldo Moro", Bari, Italy.
Mohamed LamkanfiVIB Center for Inflammation Research, Zwijnaarde, Belgium mohamed.lamkanfi@ugent.be.ORCID 0000-0003-0527-9293
Ghent University Hospital · BEGhent University · BEUniversity of Bari Aldo Moro · ITBambino Gesù Children's Hospital · ITUniversity Medical Center Utrecht · NLUniversity of Antwerp · BEXuzhou Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectiveFamilial Mediterranean fever (FMF) is the most common monogenic autoinflammatory disease (AID) worldwide. The disease is caused by mutations in the

methodsPeripheral blood mononuclear cells (PBMCs) were obtained from patients with Pyrin-associated autoinflammation with an FMF phenotype (n=43) or with autoinflammatory features not compatible with FMF (n=8), 10 asymptomatic carriers and 48 healthy donors. Sera were obtained from patients with distinct AIDs (n=10), and whole blood from a subset of patients and controls. The clinical, demographic, molecular genetic factors and other characteristics of the patient population were assessed for their impact on the diagnostic test read-out. Interleukin (IL)-1β and IL-18 levels were measured by Luminex assay.

resultsThe ex vivo colchicine assay may be performed on whole blood or PBMC. The functional assay robustly segregated patients with FMF from healthy controls and patients with related clinical disorders. The diagnostic test distinguished patients with classical FMF mutations (M694V, M694I, M680I, R761H) from patients with other

conclusionThe ex vivo colchicine assay may support diagnosis of FMF and functional subtyping of Pyrin-associated autoinflammation.

Indexed as

AdolescentAdultAgedAged, 80 and overCase-Control StudiesChildChild, PreschoolColchicineFamilial Mediterranean FeverFemaleGenetic Association StudiesHumansImmunophenotypingLeukocytes, MononuclearMaleMiddle AgedColchicineMEFV protein, humanPyrinfamilial mediterranean feverfever syndromesinflammation

Identifiers

PMID32312770
PMCPMC7307214
OpenAlexW3016747110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.